Pulmonary Tuberculosis resistant to isoniazid, rifamycins, a fluoroquinolone and a second line injectable antibacterial drug
DBCOND0154352Mycobacterial infectious disorders
Pulmonary Tuberculosis resistant to isoniazid, rifamycins, a fluoroquinolone and a second line injectable antibacterial drug is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.
- Classified under
- Indicated drugs
What you can answer from here — as of October 22, 2026
1Indicated drugWith each drug's targets and mechanismListed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for Pulmonary Tuberculosis resistant to isoniazid, rifamycins, a fluoroquinolone and a second line injectable antibacterial drug share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account